Paramount Peptides BPC-157
As of 25 Jul 2026, Finnrick has published 11 independent lab tests of BPC-157 from Paramount Peptides: 6 passed and 5 failed under the default public standard, Purity Focus (HPLC purity at least 99.5%, fill within ±35% of the label claim). The latest test is dated 3 Oct 2025. The current Finnrick rating for Paramount Peptides BPC-157 is 52%.
Finnrick ratings are recency-weighted pass percentages: newer tests count more, and vendors with thin test histories are pulled toward the peer baseline for that peptide, so a single result cannot look too certain. Samples are analyzed by independent partner laboratories and the results are published by Finnrick Analytics, which does not sell peptides and does not accept payment to alter ratings. Corrections to published data are recorded at finnrick.com/corrections.
Interactive charts, prices, and test history for this page load with JavaScript; the facts above are from Finnrick's published test database.
| Date | Result | Certificate |
|---|---|---|
| 3 Oct 2025 | Pass | Certificate 63nwdfj |
| 10 Jul 2025 | Fail | Certificate gzfk3zm |
| 5 May 2025 | Pass | Certificate yg2y9dd |
| 5 May 2025 | Pass | Certificate 1xb75di |
| 25 Apr 2025 | Fail | Certificate 0lptifl |
| 20 Mar 2025 | Pass | Certificate m59jss6 |
| 3 Mar 2025 | Fail | Certificate 6hnppxq |
| 2 Mar 2025 | Pass | Certificate uny1mz8 |
| 2 Mar 2025 | Pass | Certificate efnuook |
| 23 Jan 2025 | Fail | Certificate fzdt4fn |
| 14 Jan 2025 | Fail | Certificate 7a4kkvh |